EASY AND

EFFICIENT

LSD
SCREENING

NeoLSD™ MSMS kit

The first commercial IVD kit for screening of Pompe, MPS-I, Fabry, Gaucher,
Niemann-Pick A/B and Krabbe disorders from a single DBS sample.
 FIRST COMMERCIAL IVD KIT FOR
NEWBORN SCREENING OF SIX
A PIONEER LYSOSOMAL STORAGE DISORDERS
IN EXPANDING FROM A SINGLE DRIED BLOOD SPOT
NEWBORN PerkinElmer, a pioneer and the global leader in mass spectrometry based newborn

SCREENING
screening since 2002, currently offers the NeoBase™ Non-derivatized MSMS Kit, the
commonly used reagent in mass spectrometry based testing for amino acid, organic
acid, and fatty acid oxidation disorders, used to screen millions of babies annually.

Due to advancements in treatments of lysosomal storage disorders (LSD)

and the subsequently increase in demands for newborn screening of these
disorders, we are proud to release the NeoLSD™ MSMS Kit, the first
commercial mass spectrometry based IVD kit for newborn screening of up to six LSD
disorders from a single blood spot punch. The NeoLSD MSMS kit enables
running up to 500 tests per instrument per day. In addition, the NeoLSD™ kit
provides you a wide analytical range, leading to potenti ally lower false posi-
tive rates, less costs associated with repeat enzyme activity tests and unnecessary
molecular confirmatory testing.

Pompe Niemann-PICK A/B Gaucher

MPS-1 Krabbe Fabry

BENEFITS OF THE ASSAY

Screen for up to six LSDs from Wide dynamic range High sample volume per day
a single DBS punch and single MSMS provides you a wide With a run time of two minutes
incubation dynamic range, enabling better per sample, you can achieve
You can screen for the most separation of affected and non- a throughput that meets the
commonly occured LSDs from affected individuals, potentially demand of newborn screening
a single DBS punch, saving leading to less false positives,
time, human resources, and less costs and subsequent parent
consumables anxiety

3
 KIT INCLUDES ALL EASY ASSAY WORKFLOW
NECESSARY ITEMS
FOR EFFECTIVE OR OR

LSD NEWBORN
SCREENING Assay

Punch
1
Add Cocktail
2
Shake & Incubate
3
Quench & Mix
3.2 mm DBS Add 30 µL 37°C, 400 rpm Remove seal, add 100
to 96-well plate Cocktail, seal 18 ± 2 hours µL 50:50 MeOH:EA,
mix w/pipette.
KIT INCLUDES:
Package P1 Package P2 Package P3

1/1 2/2 NeoLSD Extraction Solution Microplate, U-bottomed

NeoLSD Kit Controls C1 C2 C3 NeoLSD Assay Buffer (1 bottle, 700 mL) (20 plates)
(3 filter paper cassettes (1 Bottle, 35 mL)
each containing 2 sets ALL 6 SUBSTRATES AND INTERNAL
of dried blood spots) STANDARDS ARE INCUBATED AT
OR THE SAME TIME IN THE SAME WELL OR OR OR OR

NeoLSD Substrates and Internal Neo MSMS Flow Solvent Microplate, Deep
Standards (5 vials, dried) (1 bottle, 800 mL) Well (10 plates)
4 5 4 6 5 4 6 5
Barcode labels for the Adhesive aluminum foil
plate (30 pcs) Transfer Liquid & Extract
microplate covers (20 sheets)
Separate Layers TransferTransfer
Liquid &Top Layer
Extract Separate Layers TransferTransfer
Liquid &Top Layer
Extract Separate Layers
To deep 96-well plate (DWP). Add 400 µL DWP centrifuge, 2 min To deep 96-wellTransfer
plate (DWP).
100 µL Add
of 400 µL DWP centrifuge, 2 min To deep 96-wellTransfer
plate (DWP).
100 µLAdd
of 400 µL DWP centrifuge, 2 min
EA & 200 µL H2O Mix with pipette. EA & 200 µL
topH2O
layerMix with pipette.
to sampling EA & 200 µL
topH2O
layerMix with pipette.
to sampling
Lot-specific quality control Adhesive microplate plate plate
certificate (1pc) covers (10 sheets)

ASSAY PRINCIPLE EXCESS SUBSTRATES WILL REMAIN IN THE

OR
AQUEOUS PHASE REDUCING THE RISK OF
IN-SOURCE FRAGMENTATION. ENZYME
PRODUCTS OF INTEREST WILL REMAIN IN THE
Enzyme activities are assessed by measuring the product generated when an enzyme reacts with a ORGANIC PHASE
synthesized specific substrate to create a specific product as shown in the equation below:
7 8 9
OROR OR
Enzyme (E) + Substrate (S) [ES complex] Enzyme + Product (P)
Dry Add Flow Solvent Shake Measure
In the NeoLSD Kit the internal standards and the enzyme-generated products are measured by Flow Add 100 µL Flow Rm temp 750 rpm
Injection Analysis – Tandem Mass Spectrometry (FIA-MSMS) using Multiple Reaction Monitoring (MRM). 77 7 88 8 99 9
Solvent 10 min
Enzymatic activities (Ae) are expressed as micromoles (µmol) per hour (h) per Liter (L) calculated from the Dry
DryDry Add
AddAdd
Flow
Flow
Flow
Solvent
Solvent
Solvent Shake
Shake
Shake Measure
Measure
Measure
peak ratio of each measured product and its associated internal standard and the known internal standard Add
Add
100
Add
100
µL
100
µLFlow
µL
Flow
Flow RmRm
temp
Rm
temp
750
temp
750
rpm
750
rpmrpm
concentrations using the formula listed below: Solvent
Solvent
Solvent 1010
minmin
10 min

Ae = {(P/IS) * [IS] * V} / (3.1 * ti * RRF) MSMS

MSMS
MSMS
MSMS

4 5
 EFFICIENT NEWBORN SCREENING
RUN UP TO The following data illustrates representative performance with the Waters® Xevo® TQD instrument.

500
Enzyme activity (µmol/L/h)
Enzyme n Lower percentiles
Range Mean Median
0.5th 1.0th
ABG 1981 2.48-52.0 11.19 10.31 3.52 3.89
ASM 1981 1.30-35.1 7.12 6.63 2.66 2.95
GALC 1981 0.30-42.2 4.68 3.91 0.79 0.97

TESTS PER DAY

IDUA 1981 2.06-22.1 7.06 6.75 2.52 2.86
GLA 1981 3.31-85.1 11.83 10.16 4.08 4.19
GAA 1981 1.98-37.2 9.77 9.07 3.45 3.77

WIDE MEASURING RANGE Enzyme activity

Enzyme
Measuring Range µmol/L/h)
ABG 0.67-19.1
ASM 0.88-20.0
GALC 0.32-6.1
IDUA 0.47-18.8
GLA 0.92-20.3
GAA 0.63-26.2

MSMS WORKSTATION SOFTWARE

Completely new software for managing, reviewing and reporting results

KEY FEATURES:

Import data from instrument software Sample and assay audit tracking
- Concentrations, IS intensties and TIC raw data
Automatic export to R4S for analysis
Automatically perform LSD specific calculations
Export results to LIMS
Visualize results
- Plate map with colored wells
- Flagging of wells violating cutoffs or other QC criteria
- View TIC & spectra
- View results by disorder
- Split grid view for easy review of results

SQL server database to store and consolidate

data from one or more MSMS instruments

Perform QC trend analysis and reporting

6 7
 COMPLETE MASS SPECTROMETRY
SOLUTIONS FOR NEWBORN SCREENING.
A COMMUNITY OF SUPPORT
From dried blood spot cards, punchers, instruments, reagents to informatics, PerkinElmer's mass spectrometry
solutions empower newborn screening laboratories across the globe to meet their demands.

By joining the PerkinElmer newborn screening community, you become part of a movement that includes the
majority of the newborn screening laboratories and leaders worldwide. In addition to all necessary equipment,
reagents and informatics, we also provide on-site installation and training, ongoing support, phone consults and
various training courses. We are here to help you improve your newborn screening program.

WHY SCREEN FOR LYSOSYMAL STORAGE DISORDERS?

LSDs comprise a heterogeneous group of nearly 50 disorders observation can be difficult. Enzyme replacement therapy or
that are caused by genetic defects resulting in the dysfunc- hematopoietic stem cell transplantation are available to treat
tion, deficiency or absence of a lysosomal enzyme. Although some LSDs, however, if an available therapy is delayed, irre-
each disorder is rare, LSDs as a group have a frequency of versible tissue damage may result.
1 in 7,000-8,000 live births. Affected individuals are unable
to metabolize the disease specific substrate of the deficient Infantile onset forms of some LSDs (Pompe and Krabbe disease)
lysosomal enzyme, which leads to progressive accumulation may be fatal within the first year of life when left untreated.
of the substrate in the lysosomes of tissues. Mutations that Early diagnosis and treatment is essential to the wellbeing of
result in an LSD are highly heterogeneous. Affected individ- individuals with these diseases.
uals exhibit a broad variety of disease severities with wide-
spread symptoms and ages of onset. Because symptoms are
absent at birth, early diagnosis of these diseases by clinical

Products may not be licensed in accordance with the laws in all countries, such as Canada.
Please check with your local representative for availability.

PerkinElmer, Inc. PerkinElmer, Inc. ISO 13485

940 Winter Street Wallac Oy ISO 9001
Waltham, MA 02451 USA PO Box 10 CMDCAS
P: (800) 762-4000 or 20101 Turku, Finland ISO 14001
(+1) 203-925-4602 Phone: + 358 2 2678 111 OHSAS 18001
www.perkinelmer.com Fax: + 358 2 2678 357

For a complete listing of our global offices, visit www.perkinelmer.com/ContactUs

Copyright ©2018, PerkinElmer, Inc. All rights reserved. PerkinElmer® is a registered trademark of PerkinElmer, Inc. All other trademarks are the property of their respective owners.

1599-9813-03 BRO MSMS NeoLSD kit November 2018 Printed in Finland